Lupus nephritis and multiple sclerosis

Various scientific studies and scientists suggest that artemisinin and/or its derivatives, in combination with other molecules, could have a positive influence in the treatment of diverse autoimmune diseases by inhibiting proliferation and survival of self-reactive T-cells, which are the cause of these diseases. Additionally, artemisinin acts on other parts of the immune system, such as activation of macrophages, creating a synergistic effect that has so far been shown in the preclinical phase for multiple sclerosis. Effective treatment for lupus nephritis could also be a reality in the near future, with various clinical trials underway (phase 2 and 4).

References: